Rolitetracycline
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Other names | (2Z,4S,4aS,5aS,6S,12aS)-4-Dimethylamino-6,10,11,12a-tetrahydroxy-2-[hydroxy-(pyrrolidin-1-ylmethylamino)methylidene]-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.938 |
| Chemical and physical data | |
| Formula | C27H33N3O8 |
| Molar mass | 527.574 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Rolitetracycline is a tetracycline antibiotic. Tetracycline is N-Mannich base prodrug that is prepared from tetracycline by condensation with pyrrolidine and formaldehyde to produce rolitetracycline. Rolitetracycline is used as an antibacterial drug, a protein synthesis inhibitor, an antiprotozoal drug and a prodrug.
| 30S |
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50S |
|
||||||||||||||||||
| EF-G |
|
||||||||||||||||||
| |||||||||||||||||||